{"id":"NCT03861039","sponsor":"Eli Lilly and Company","briefTitle":"A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes","officialTitle":"A Phase 3, Long-Term Safety Study of Tirzepatide in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus (SURPASS J-combo)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-30","primaryCompletion":"2021-01-26","completion":"2021-02-16","firstPosted":"2019-03-04","resultsPosted":"2022-02-14","lastUpdate":"2022-02-14"},"enrollment":443,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Oral antihyperglycemic medication (OAM)","otherNames":[]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the long-term safety of the study drug tirzepatide in combination with oral antihyperglycemic medications in participants with type 2 diabetes.","primaryOutcome":{"measure":"Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration","timeFrame":"Baseline through Week 52","effectByArm":[{"arm":"5 mg Tirzepatide","deltaMin":0,"sd":null},{"arm":"10 mg Tirzepatide","deltaMin":1,"sd":null},{"arm":"15 mg Tirzepatide","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":34,"countries":["Japan"]},"refs":{"pmids":["40711720","35914542"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/2qJ9f49B7nrO6hGapNnDZD"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":148},"commonTop":["Nasopharyngitis","Nausea","Constipation","Diarrhoea","Decreased appetite"]}}